COMPASS Pathways (CMPS)
NASDAQ: CMPS
· Real-Time Price · USD
4.63
0.24 (5.47%)
At close: Jun 16, 2025, 3:59 PM
4.65
0.32%
After-hours: Jun 16, 2025, 07:17 PM EDT
5.47% (1D)
| Bid | 4.6 |
| Market Cap | 430.35M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -137.8M |
| EPS (ttm) | -1.99 |
| PE Ratio (ttm) | -2.33 |
| Forward PE | -3.24 |
| Analyst | Buy |
| Ask | 4.65 |
| Volume | 1,640,274 |
| Avg. Volume (20D) | 1,161,055 |
| Open | 4.50 |
| Previous Close | 4.39 |
| Day's Range | 4.42 - 4.67 |
| 52-Week Range | 2.49 - 8.54 |
| Beta | 2.25 |
About CMPS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CMPS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CMPS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+6.21%
Mind Medicine and Compass Pathways shares are trad...
Unlock content with
Pro Subscription
3 months ago
+5.95%
Compass Pathways shares are trading higher. The company reported Q4 financial results.
2 weeks ago · https://www.proactiveinvestors.com
Meta to roll out AI-powered ad creation by late 2025, says WSJMeta Platforms Inc (NASDAQ:META, ETR:FB2A, SWX:FB) is planning to let brands fully create and target ads using its artificial intelligence tools by the end of 2025, according to a report in the Wall S...
1 month ago · businesswire.com
Compass Pathways to Announce First Quarter Financial Results on May 8, 2025LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal...
